NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$150.19
Tradestie Score
63
Market Cap
$254.99B
P/E Ratio
20.8
Revenue Growth
0.0%
Analyst Upside
+2.5%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$230.06
|
$448.07B | 25.6 | 61 | Compare |
|
ABBV
ABBVIE INC.
|
$211.13
|
$431.71B | 99.4 | 63 | Compare |
|
NVO
Novo-Nordisk A/S
|
$46.04
|
$262.92B | 10.8 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$185.61
|
$261.56B | 27.9 | 48 | Compare |
|
MRK
Merck & Co., Inc.
|
$112.96
|
$225.13B | 31.3 | 61 | Compare |
|
AMGN
Amgen Inc
|
$336.49
|
$160.70B | 22.9 | 58 | Compare |
|
PFE
Pfizer Inc.
|
$25.79
|
$154.70B | 19.7 | 59 | Compare |
|
GILD
Gilead Sciences Inc
|
$132.75
|
$137.92B | 18.2 | 59 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.73
|
$121.27B | 18.2 | 55 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$56.68
|
$96.54B | 15.7 | 56 | Compare |
More NVS Analysis
Data updated: May 14, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry